Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease
International Journal of Rheumatic Diseases · 2026-11 · 29 (11)
DOI: 10.1111/1756-185x.70909 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 02.11.2026. Verfasst von Chufan Qu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology Immunology & Allergy, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Rheumatology Immunology & Allergy, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Chufan Qu, Meiping Lu
Zitieren
APA
Qu, C., & Lu, M. (2026). Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease. International Journal of Rheumatic Diseases, 29(11). https://doi.org/10.1111/1756-185x.70909
Vancouver
Qu C, Lu M. Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease. International Journal of Rheumatic Diseases. 2026;29(11). doi:10.1111/1756-185x.70909
BibTeX
@article{Qu2026,
author = {Qu, Chufan and Lu, Meiping},
title = {Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
volume = {29},
number = {11},
doi = {10.1111/1756-185x.70909}
}
EUVIMED